Search details
1.
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition.
NPJ Precis Oncol
; 8(1): 3, 2024 Jan 05.
Article
in English
| MEDLINE | ID: mdl-38182677
2.
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden.
Neurooncol Pract
; 6(2): 103-111, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-31386050
Results
1 -
2
de 2
1
Next >
>>